ICON PLC
NASDAQ:ICLR

Watchlist Manager
ICON PLC Logo
ICON PLC
NASDAQ:ICLR
Watchlist
Price: 213.26 USD 1.54% Market Closed
Market Cap: 17.6B USD
Have any thoughts about
ICON PLC?
Write Note

ICON PLC
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ICON PLC
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
ICON PLC
NASDAQ:ICLR
Tax Provision
-$58.9m
CAGR 3-Years
-12%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
M
Malin Corporation PLC
ISEQ:MLC
Tax Provision
€0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

ICON PLC
Glance View

Market Cap
17.6B USD
Industry
Life Sciences Tools & Services

In the rapidly evolving landscape of global healthcare, ICON PLC stands out as a formidable player, seamlessly bridging the gap between innovative drug development and practical clinical application. Founded in Dublin, Ireland, ICON has grown into a multinational enterprise, deeply embedded in the research and development phases of various medical and biopharmaceutical companies. The company's core strength lies in its ability to offer comprehensive clinical trial services, encompassing every stage of drug development, from initial study design through to final data management and regulatory submissions. ICON's systematic approach not only shortens the timeline for bringing novel therapeutics to market but also ensures that these breakthroughs are both effective and safe, thereby garnering trust from clients ranging from burgeoning biotech startups to pharmaceutical giants. As a contract research organization (CRO), ICON operates within a business model designed to capitalize on the booming demand for outsourced R&D support. This model involves entering into strategic partnerships with clients to conduct all necessary research activities in exchange for fees, which can be structured through agreements for specific projects or longer-term collaborations. The company leverages its robust network, sophisticated technological platforms, and expert workforce to offer tailored solutions that optimize efficiency and accuracy. By doing so, ICON not only enhances its clients’ product pipelines but also secures a steady stream of revenue, further consolidated through repeat business and the expansion of its service repertoire to include emerging areas like digital health and real-world evidence. This disciplined and innovative approach propels ICON's growth, ensuring its financial health and reaffirming its integral role in driving medical advancement worldwide.

ICLR Intrinsic Value
303.73 USD
Undervaluation 30%
Intrinsic Value
Price

See Also

What is ICON PLC's Tax Provision?
Tax Provision
-58.9m USD

Based on the financial report for Sep 30, 2024, ICON PLC's Tax Provision amounts to -58.9m USD.

What is ICON PLC's Tax Provision growth rate?
Tax Provision CAGR 10Y
-7%

Over the last year, the Tax Provision growth was -12%. The average annual Tax Provision growth rates for ICON PLC have been -12% over the past three years , -4% over the past five years , and -7% over the past ten years .

Back to Top